skip to main content
iatroX JournalMRCGP

Heidi Evidence vs iatroX (2026)

Featured image for Heidi Evidence vs iatroX (2026)

Heidi Evidence and iatroX can both support source-linked clinical questions; the useful choice depends on the question, local context and what the clinician wants to do after reading the answer. Updated on 22 September 2026, this comparison considers evidence searches during clinic, UK primary-care pathways and examination revision as distinct tasks rather than assuming that one tool must suit every situation.

This piece is published by iatroX and includes iatroX among the tools compared. The product descriptions below are dated public information or iatroX's supplied September 2026 specification, not results of a controlled head-to-head test.

At a Glance

Who is it for?

The original comparison described Heidi Evidence as useful for clinicians wanting fast cited answers, often alongside Heidi Scribe. It described iatroX as useful for UK clinicians and trainees needing guideline-grounded support. Those are intended-use scenarios rather than exclusive user categories. The original comparison, checked on 22 September 2026, supplies that framing.

Why choose Heidi Evidence?

The earlier page highlighted source selection, an answer-first workflow with visible references, a polished interface and a natural fit for clinicians already using Heidi documentation. Heidi's Evidence page, checked on 22 September 2026, describes source prioritisation and source-linked answers, supporting those product-design points. "Polished" and "fast" remain qualitative judgements here, not timings measured for this article. Heidi Evidence provides the current first-party description.

Why choose iatroX?

The original page highlighted UK primary-care and NHS decision-pathway relevance, the combination of Ask, Brainstorm and Quiz, and utility for reflection and examination preparation. Per iatroX product information, September 2026, these are complementary reference and learning functions. Ask-iatroX, Brainstorm and the question-bank entry point are the verified product destinations.

Feature Comparison

The original comparison's categories are retained below, with scope made explicit as of 22 September 2026.

CapabilityHeidi EvidenceiatroX
Core workflowAnswer-first evidence search with source-linked outputGuideline-grounded questions alongside reasoning and practice functions
UK primary-care fitAssess the sources selected and the local context suppliedUK-facing source design; still requires checking applicability and local pathways
Documentation suiteConnected to the wider Heidi documentation propositionNot a scribe; focuses on reference and learning
Training and revisionReference can support reading and study; CPD functionality is publicly describedBrainstorm, quizzes and the paid structured-learning bundle

The starting categories come from the existing comparison. Current Heidi reference and CPD positioning comes from Heidi Evidence, checked on 22 September 2026. iatroX's descriptions follow its September 2026 product specification and published methodology. The table compares product roles, not measured accuracy.

In-Depth Analysis

Overview

The earlier overview presented Heidi as a modern, source-selectable evidence-answer layer and iatroX as a stronger fit when the job involved UK guideline execution. The useful distinction is one of intended workflow, not proof that iatroX produces a better answer to every UK question. The original page did not supply a controlled comparison establishing that result. The previous overview is the source of that editorial positioning.

Per iatroX product information, September 2026, Ask-iatroX uses NICE, CKS, SIGN and SmPC information from emc with linked sources. Its methodology describes retrieval, ranking, citation grounding, output checking and uncertainty handling. These features are intended to make the answer traceable and contextually useful; they do not guarantee that an output is correct. The methodology explains the design.

Heidi's Evidence page, checked on 22 September 2026, also emphasises traceable sources and selection of preferred source sets. A clinician should examine whether the source supports the particular claim, whether the population matches the question and whether local service arrangements alter the practical next step. Heidi's product page establishes the reference functions, not universal applicability.

Key Differences

The original recommendation was Heidi for a polished, source-selectable evidence layer, particularly within an existing Heidi workflow, and iatroX for UK guideline-first support combined with case reasoning and revision. Those are sensible scenarios to investigate, but they should not be turned into a fixed product hierarchy.

Per iatroX product information, September 2026, its Socratic Tutor opens on an attempted question and uses targeted follow-ups to identify a misconception. Its adaptive question banks and spaced repetition support structured revision. Tutor and the learning entry point describe a learning task that goes beyond reading an answer, without implying that Heidi cannot support learning or record CPD.

Practical Reality

The original page recognised that clinicians may use Heidi for documentation and rapid evidence summarisation, then iatroX for a UK-facing pathway question or to pressure-test their understanding of a plan. That complementary use remains more realistic than insisting on a permanent exclusive choice.

For a fictional clinician reviewing an unfamiliar pathway after clinic, the first task may be to locate the relevant source. The second may be to explain why a tempting alternative is not appropriate in the scenario. The third may be to revisit the distinction later through a question or case. Those are different tasks even when they occur during the same learning session.

Use-Cases

Quick evidence sense-check during clinic

When to choose Heidi Evidence

The original page favoured Heidi for speed and user experience when a question was broad or literature-focused. That is a relevant use case, although an independently established speed advantage has not been demonstrated here. As of 22 September 2026, its published source-linked, answer-first design makes it a reasonable option to examine for that task. Heidi Evidence supplies the product description.

When to choose iatroX

The original page highlighted iatroX where the question specifically concerned a UK guideline or pathway. Per iatroX product information, September 2026, that is consistent with Ask-iatroX's source design. The reader still needs to check the cited material rather than assume that the platform's orientation settles every local decision.

What should I do next in UK primary care?

When to choose Heidi Evidence

The earlier comparison emphasised source selection and local-context prompting. That remains a useful assessment question, but it should not imply that only Heidi needs adequate context. Any source-linked response can be incomplete when the question omits information that changes its applicability.

When to choose iatroX

The original page favoured iatroX as a guideline-first, NHS-facing next-step resource. Treat that as a fit-based judgement. In a fictional pathway exercise, ask whether the answer identifies uncertainty, distinguishes national guidance from local arrangements and links to the relevant source. No current comparative result is claimed.

Exam revision / AKT-style learning

When to choose Heidi Evidence

The original description of Heidi as a useful reading aid remains a fair educational role. Its publicly described CPD functionality, checked on 22 September 2026, should also be acknowledged. A reference answer can support learning without being the whole examination-preparation workflow. Heidi Evidence provides that product context.

When to choose iatroX

Per iatroX product information, September 2026, the paid bundle includes adaptive question banks covering more than forty examinations, spaced repetition, Socratic Tutor, an exam-date-aware planner, simulations and CPD tools. The relevant value for an AKT learner is several methods supporting that goal, not access to unrelated examinations. The question-bank entry point is the appropriate learning route.

Free access, subscription and CPD

Per iatroX product information, September 2026, Ask-iatroX and free question access have no trial expiry or verification gate. The full paid learning subscription costs £99 annually, paid upfront, equivalent to £8.25 a month billed annually, or £29 a month. Simulations and CPD are included, not separate add-ons; three monthly payments total £87 and four total £116, making annual access cheaper from the fourth month.

Per the same September 2026 specification, iatroX CPD includes profession and practice-context selection, learner review and personalisation, PDF export and direct FourteenFish export for linked accounts. Completed evidence remains accessible after the subscription ends. iatroX CPD describes a professional learning-record workflow, not automatic formally accredited CME. Heidi also markets CPD-related functionality, so logging alone is not an exclusive distinction.

What the new financing adds to this comparison

Heidi's 22 September 2026 announcement describes US$100 million Series C equity alongside US$240 million growth investment. Its 31 July 2026 technical post reported a 49.9% clinician-preference result against Sonnet 4.6 for out-of-session Evidence. These are separate financial and technical facts, neither of which establishes superiority over iatroX in a clinical head-to-head test. The financing announcement and technical account supply the dated claims.

The forthcoming capabilities in Heidi's September announcement are excluded from the UK and EU; that does not remove existing Evidence services. Use iatroX's funding-and-free-evidence strategy article for the commercial implications, rather than treating the announcement as a new local entitlement. Heidi's release provides the regional qualification.

Verdict by reader scenario

For rapid cited reference within an established Heidi workflow, assess Evidence first. For free UK-facing reference, assess Ask-iatroX against the actual guideline question. For a defined examination goal, compare structured attempts, feedback and progression rather than answer length. For CPD, consider how well the record reflects personally reviewed learning. These scenarios preserve the original page's practical distinctions without claiming a universal winner.

Frequently asked questions

Are Heidi Evidence and Ask-iatroX both free?

Heidi publicly markets free Evidence access as checked on 22 September 2026, while iatroX's September 2026 specification confirms free Ask-iatroX without trial expiry or a verification gate. Account-specific Heidi entitlements and separate paid learning features should be checked independently.

Does a UK-focused source design prove higher accuracy?

No: it describes the intended source and workflow fit. Correctness still requires checking the output and relevant evidence, and no controlled head-to-head accuracy result is claimed here.

Which is better for AKT-style revision?

A learner wanting adaptive questions, targeted tutoring and an exam-aware study journey should assess iatroX's paid learning bundle. Someone who mainly wants cited reading alongside existing revision materials may find a free reference tool sufficient.

Explore targeted questions and clinical learning with iatroX →

Back to Journal